{
    "code": "01000165",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01000165",
    "time": "2020-02-25 01:30:42",
    "許可證字號": "衛署藥製字第000165號",
    "註銷狀態": "已註銷",
    "註銷日期": "77\/07\/19",
    "註銷理由": "安用科更新資料",
    "有效日期": "75\/11\/11",
    "發證日期": "60\/11\/11",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00100016508",
    "中文品名": "持續性保寧注射液",
    "英文品名": "PRIMOBOLAN DEPOT INJECTION",
    "適應症": "骨骼疏鬆症、男性性腺機能不足症、手術後、外傷、熱傷、慢性腎臟疾病引起之體質極度消耗、再生不良性貧血引起之骨髓消耗狀態",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "01國　產",
        "申請商名稱": "1408703200  臺灣赫美龍股份有限公司",
        "申請商地址": "桃園巿桃園區大誠路１１號",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6808001810",
            "成分名稱": "METHENOLONE ENANTHATE (METENOLONE ENANTHATE)",
            "含量描述": "100",
            "含量": "100.0000000000",
            "單位": "MG"
        }
    ]
}